Home | Site Index | Contact Us
	Developing therapies for infectious diseases has been a hallmark for Valeant for over 30 years beginning with our initial discovery of ribavirin in the 1970's. Read More Valeant has rapidly expanded it's neurological business over the past three years through the acquisitions of several products. These products provide hope for relief to patients suffering from debilitating diseases. Read More Our dermatology products help patients who are suffering from actinic keratoses, superficial basal cell carcinomas, and severe psoriasis. Read More
	TARIBAVIRIN and RETIGABINE are products in clinical development. None of them have been found to be safe or effective for the treatment of any disease or illness. They may not be sold or promoted in the United States unless and until they are approved by the FDA. Similar restrictions apply in other countries.
	© Valeant Pharmaceuticals International 2007 Legal and Privacy Statement